BD Overview

Facts About BD



Facts About BD   |  Corporate Governance  |   More than a Century of Quality   |   BD Worldwide Business Segments   |   BD Annual Report   |   About BD   |   BD Products  

BD is a leading global medical technology company that develops, manufactures and sells medical devices, instrument systems and reagents. The Company is dedicated to improving people's health throughout the world. BD is focused on improving drug delivery, enhancing the quality and speed of diagnosing infectious diseases and cancers, and advancing research, discovery and production of new drugs and vaccines. BD's capabilities are instrumental in combating many of the world's most pressing diseases. Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD employs nearly 30,000 associates in more than 50 countries throughout the world. The Company serves healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. For more information, please visit www.bd.com.
 
  • BD focuses strategically on achieving growth in three worldwide business segments: BD Medical, BD Diagnostics and BD Biosciences

  • Revenues were $7.7 billion for the fiscal year ended September 30, 2012.

  • In FY 2012, BD invested $472 million in research and development.

  • BD was founded as a partnership in 1897, incorporated in 1906. BD became a publicly held company in 1962. The stock is traded on the New York Stock Exchange with the symbol BDX.

  • BD employs nearly 30,000 associates worldwide in more than 50 countries.

Return to Top